Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

EU Committee to reconsider zinc oxide decision
Piglet
The NPA estimates that between 70 - 90 per cent of piglet diets contain zinc oxide at therapeutic levels.

Announcement welcomed by pig producers

The European Committee is to reconsider its recommendation to withdraw veterinary medicines containing zinc oxide, following a number of appeals from across the EU.

In December, the EU Committee for Medicinal Products for Veterinary Use (CVMP) called for a ban on zinc oxide in response to concerns over its risk to the environment.

The committee claimed that the treatment benefits of zinc oxide for the prevention of diarrhoea in pigs did not outweigh the environmental risk associated with their use.

In light of recent fightback, the CVMP has decided to reevaluate its opinion, suggesting that this will be reached by the beginning of April. Once the final opinion is published, the EU Commission will begin the formal decision-making process.

Welcoming the news, National Pig Association (NPA) chief executive Zoe Davis said: “We will continue to argue that the huge benefits of using zinc oxide in piglet feed far outweigh any environmental costs, which can be mitigated by either adopting a regional approach or reducing inclusion levels."

Last week, the National Pig Association (NPA) issued a briefing to the VMD - which represents the UK on the CVMP - outlining the impact of zinc oxide ban on the pig industry.

The NPA estimates that between 70 - 90 per cent of piglet diets contain zinc oxide at therapeutic levels, meaning a ban would cause ‘widespread deterioration in pig health and welfare’.

"Losing medicinal zinc oxide would seriously hamper the ability of the pig sector to further reduce its use of antibiotics. An increased use of antibiotics above their current levels may, in turn, result in further development of bacterial resistance, jeopardising the health of both animals and humans," the NPA briefing said.

The briefing also addressed concerns about environmental pollution from the use of zinc oxide. It pointed out that the application rate of zinc oxide onto UK soils from pig slurry is estimated to be well below the limit applied by Defra and the Environment Agency.

It concluded: "NPA is strongly against any ban on the therapeutic use of zinc oxide and instead would favour either a regionalised application of policy or an approach that reduces the inclusion levels of zinc oxide to minimise environmental risk without jeopardising pig health and welfare."

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.